blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4027978

EP4027978 - COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC BIOLOGICS FOR TREATMENT OF DISEASE [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  27.04.2024
Database last updated on 26.07.2024
FormerRequest for examination was made
Status updated on  17.06.2022
FormerThe international publication has been made
Status updated on  20.03.2021
Formerunknown
Status updated on  06.10.2020
Most recent event   Tooltip30.04.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Elektrofi, Inc.
451 D Street, Suite 707
Boston, MA 02210 / US
[2022/29]
Inventor(s)01 / BROWN, Paul
451 D Street, Suite 707
Boston, MA 02210 / US
02 / CARTER, Tyler L.
451 D Street, Suite 707
Boston, MA 02210 / US
03 / CHARLES, Lyndon Fitzgerald, Jr.
451 D Street, Suite 707 Boston
Boston, MA 02210 / US
04 / COFFMAN, Chase Spenser
451 D Street, Suite 707
Boston, MA 02210 / US
05 / DADON, Daniel Benjamin
451 D Street, Suite 707
Boston, MA 02210 / US
06 / LIU, Lisa
451 D Street, Suite 707
Boston, MA 02210 / US
07 / SHADBAR, Sadiqua
451 D Street, Suite 707
Boston, MA 02210 / US
08 / SUDRIK, Chaitanya
451 D Street, Suite 707
Boston, MA 02210 / US
09 / TANG, Yi
451 D Street, Suite 707
Boston, MA 02210 / US
10 / VARTAK, Shankul
451 D Street, Suite 707
Boston, MA 02210 / US
 [2022/29]
Representative(s)De Clercq & Partners
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
[2022/29]
Application number, filing date20780524.311.09.2020
[2022/29]
WO2020US50508
Priority number, dateUS201962899981P13.09.2019         Original published format: US 201962899981 P
US201962899907P13.09.2019         Original published format: US 201962899907 P
US202063024703P14.05.2020         Original published format: US 202063024703 P
[2022/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021050953
Date:18.03.2021
Language:EN
[2021/11]
Type: A1 Application with search report 
No.:EP4027978
Date:20.07.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 18.03.2021 takes the place of the publication of the European patent application.
[2022/29]
Search report(s)International search report - published on:EP18.03.2021
ClassificationIPC:A61K9/10, A61K38/00, A61K47/14, A61P35/00
[2022/29]
CPC:
A61K9/0019 (EP); A61K39/395 (CN); C07K16/00 (US);
A61K45/06 (EP,CN,US); A61K47/14 (EP,CN); A61K9/10 (EP,CN);
A61K9/1623 (CN); A61K9/1652 (CN); A61P35/00 (EP,CN);
A61P35/02 (CN); A61P37/02 (CN); A61K38/00 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/29]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR ABGABE VON THERAPEUTISCHEN BIOLOGIKA ZUR BEHANDLUNG VON KRANKHEITEN[2022/29]
English:COMPOSITIONS AND METHODS FOR THE DELIVERY OF THERAPEUTIC BIOLOGICS FOR TREATMENT OF DISEASE[2022/29]
French:COMPOSITIONS ET PROCÉDÉS POUR L'ADMINISTRATION DE PRODUITS BIOLOGIQUES THÉRAPEUTIQUES POUR LE TRAITEMENT D'UNE MALADIE[2022/29]
Entry into regional phase12.04.2022National basic fee paid 
12.04.2022Designation fee(s) paid 
12.04.2022Examination fee paid 
Examination procedure12.04.2022Amendment by applicant (claims and/or description)
12.04.2022Examination requested  [2022/29]
12.04.2022Date on which the examining division has become responsible
29.04.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
18.07.2022Renewal fee patent year 03
24.08.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2009274765  (BEDUNEAU ARNAUD [US], et al) [Y] 1-329* claims 1-36 *;
 [XY]US2014308270  (LOBO BRIAN [US], et al) [X] 1-23 * the whole document * [Y] 1-329;
 [XY]US2014378370  (JOHNSTON KEITH P [US], et al) [X] 1,148,149,160-167,174-195,311-321 * the whole document * * claims 51-56 * [Y] 1-329;
 [XY]WO2018098376  (ELEKTROFI INC [US]) [X] 1,24-30,52-54,66-133,159-163,190-202,224-230,238-305 * the whole document * [Y] 1-329;
 [XY]WO2019023392  (ELEKTROFI INC [US]) [X] 1,24-58,66-138,195-230,238-310 * the whole document * [Y] 1-329;
 [XP]WO2019226969  (ELEKTROFI INC [US]) [XP] 1,24-90,96-138,147,148,159-163,195-262,268-310,320 * the whole document *
by applicantUS4172896
 US5358970
 US5427798
 US5541231
 US5595721
 US5677180
 US5731000
 US5736137
 US5739169
 US5763493
 US5801005
 US5824311
 US5830880
 US5846945
 US6110973
 WO2007059782
    - WARD et al., Nature, (19890000), vol. 341, pages 544 - 546
    - HOLT et al., Trends Biotechnol, (20031100), vol. 21, no. 11, pages 484 - 90
    - REVETS et al., Expert Opin Biol Ther, (20050100), vol. 5, no. 1, pages 111 - 24
    - BIRD et al., Science, (19880000), vol. 242, pages 423 - 426
    - PLUCKTHUN, THE PHARMACOLOGY OF MONOCLONAL ANTIBODIES, Springer-Verlag, (19940000), vol. 113, pages 269 - 315
    - CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628
    - MARKS et al., J. Mol. Biol, (19910000), vol. 222, pages 581 - 597
    - SBLATTEROBRADBURY, Nature Biotechnology, (20000000), vol. 18, pages 75 - 80
    - PERSIC et al., Gene, (19970000), vol. 187, pages 9 - 18
    - MORRISON et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6851 - 6855
    - PRESS et al., Blood, (19870000), vol. 69, no. 2, pages 584 - 591
    - VALENTINE et al., Leukocyte Typing, Oxford University Press, (19870000), vol. III, page 440
    - MILLER et al., J. Pharm. Sci., (20120000), vol. 101, pages 3763 - 3778
    - Peptide and Protein Drug Delivery, Marcel Dekker, Inc., (19910000), pages 247 - 301
    - JONES, A., Adv. Drug Delivery Rev., (19930000), vol. 10, pages 29 - 90
    - FROST, G. I., "Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration", Expert Opinion on Drug Delivery, (20070000), vol. 4, doi:10.1517/17425247.4.4.427, pages 427 - 440, XP008177677

DOI:   http://dx.doi.org/10.1517/17425247.4.4.427
    - MAHJ et al., Exp Toxicol Path, (20060000), vol. 57, pages 341 - 5
 US19960627996
 US20070628999
 US19810628999
 US19410629786
 US20200630118
 WO2017US63150
 WO2018US43774
 WO2019US33875
 WO2020US15957
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.